I agree that it is way undervalued and I don't think MANY will argue that. I understand you're basing that on revenue and that's one reason why I like this bio so much right now. Not included are two huge factors that need to be. Advancement in treatments and a rapidly growing industry. This should be trading way higher than that. I believe .50. $USRM